Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy (Q34971424)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

randomized controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Suhnggwon Kim

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2

object named as

Ho Jun Chin

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Yong-Chul Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ho Suk Koo

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

19 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

e71545

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

19 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Mortality of IgA nephropathy patients: a single center experience over 30 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Corticosteroid therapy in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Current therapy for IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Predicting the risk for dialysis or death in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Predicting renal outcome in IgA nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

The commonest glomerulonephritis in the world: IgA nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

8 July 2018

Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

A tricontinental view of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071545

21 January 2018

Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Antiproteinuric effect of olmesartan in patients with IgA nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3747236

26 October 2018

Proteinuria in IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of proteinuria improves prognosis in IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course and prognostic factors of clinical early IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23977072

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0071545

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2013PLoSO...871545K

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34971424&oldid=2045772253"